These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18665799)

  • 1. N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster.
    Matsuhisa S; Otani H; Okazaki T; Yamashita K; Akita Y; Sato D; Moriguchi A; Iwasaka T
    Antioxid Redox Signal; 2008 Dec; 10(12):1999-2008. PubMed ID: 18665799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 1 receptor blocker preserves tolerance to ischemia-reperfusion injury in Dahl salt-sensitive rat heart.
    Matsuhisa S; Otani H; Okazaki T; Yamashita K; Akita Y; Sato D; Moriguchi A; Imamura H; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2473-9. PubMed ID: 18390819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemin decreases cardiac oxidative stress and fibrosis in a rat model of systemic hypertension via PI3K/Akt signalling.
    Worou ME; Belmokhtar K; Bonnet P; Vourc'h P; Machet MC; Khamis G; Eder V
    Cardiovasc Res; 2011 Jul; 91(2):320-9. PubMed ID: 21406596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of oxidative/nitrosative stress in the tolerance to ischemia/reperfusion injury in cardiomyopathic hamster heart.
    Kyoi S; Otani H; Matsuhisa S; Akita Y; Enoki C; Tatsumi K; Hattori R; Imamura H; Kamihata H; Iwasaka T
    Antioxid Redox Signal; 2006; 8(7-8):1351-61. PubMed ID: 16910782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
    Bourraindeloup M; Adamy C; Candiani G; Cailleret M; Bourin MC; Badoual T; Su JB; Adubeiro S; Roudot-Thoraval F; Dubois-Rande JL; Hittinger L; Pecker F
    Circulation; 2004 Oct; 110(14):2003-9. PubMed ID: 15451797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide ameliorated L-NAME-induced hypertensive heart disease by the Akt/eNOS/NO pathway.
    Jin S; Teng X; Xiao L; Xue H; Guo Q; Duan X; Chen Y; Wu Y
    Exp Biol Med (Maywood); 2017 Dec; 242(18):1831-1841. PubMed ID: 28971696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
    Yasuda S; Kobayashi H; Iwasa M; Kawamura I; Sumi S; Narentuoya B; Yamaki T; Ushikoshi H; Nishigaki K; Nagashima K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1558-65. PubMed ID: 19286954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T; Otani H; Yoshioka K; Fujita M; Okazaki T; Iwasaka T
    Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H2061-72. PubMed ID: 21890687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Losartan, an angiotensin II type 1 receptor blocker, ameliorates cerebral ischemia-reperfusion injury via PI3K/Akt-mediated eNOS phosphorylation.
    Liu H; Liu X; Wei X; Chen L; Xiang Y; Yi F; Zhang X
    Brain Res Bull; 2012 Oct; 89(1-2):65-70. PubMed ID: 22766267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179.
    Watanabe T; Suzuki J; Yamawaki H; Sharma VK; Sheu SS; Berk BC
    Circulation; 2005 Sep; 112(12):1798-805. PubMed ID: 16172287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure.
    Fukushima H; Kobayashi N; Takeshima H; Koguchi W; Ishimitsu T
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):83-8. PubMed ID: 19904215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts.
    Kobayashi N; Yoshida K; Nakano S; Ohno T; Honda T; Tsubokou Y; Matsuoka H
    Hypertension; 2006 Apr; 47(4):671-9. PubMed ID: 16505212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure.
    Zhang P; Xu X; Hu X; van Deel ED; Zhu G; Chen Y
    Circ Res; 2007 Apr; 100(7):1089-98. PubMed ID: 17363700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress.
    Escobales N; Crespo MJ
    Vascul Pharmacol; 2006 Jan; 44(1):22-8. PubMed ID: 16301003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size.
    Ye Y; Keyes KT; Zhang CF; Perez-Polo JR; Lin Y; Birnbaum Y
    Cardiovasc Drugs Ther; 2010 Apr; 24(2):107-20. PubMed ID: 20379769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
    Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic use of selective iNOS inhibitor 1400W or non-selective NOS inhibitor l-NAME differently affects systemic nitric oxide formation after oral Porphyromonas gingivalis inoculation in mice.
    Nemec A; Pavlica Z; Petelin M; Crossley DA; Sentjurc M; Jerin A; Erzen D; Zdovc I; Hitti T; Skaleric U
    Arch Oral Biol; 2010 Jul; 55(7):509-14. PubMed ID: 20430367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
    Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
    Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.